1996
DOI: 10.1136/jnnp.61.2.172
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum toxin in writer's cramp: objective response evaluation in 31 patients.

Abstract: Objectives-To quantify the treatment effect oflocal botulinum toxin injections in writer's cramp a newly developed rating scale of writing performance and a computer assisted analysis of writing speed were used in 31 patients undergoing botulinum toxin therapy.Methods-Baseline data of the writer's cramp rating scale (WCRS, see appendix) and computer based writing speed analysis were compared with those obtained at the time of subjective best response as recorded during follow up visits. Results-The mean dose i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
88
0
3

Year Published

1999
1999
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 144 publications
(95 citation statements)
references
References 11 publications
4
88
0
3
Order By: Relevance
“…We also confirmed the diagnosis with four-channel surface electromyography recorded from the involved upper extremity. For objective clinical assessments, we used the methods described by Wissel et al [7]. Informed consent to the surgical treatment was obtained from the patient and the family.…”
Section: Methodsmentioning
confidence: 99%
“…We also confirmed the diagnosis with four-channel surface electromyography recorded from the involved upper extremity. For objective clinical assessments, we used the methods described by Wissel et al [7]. Informed consent to the surgical treatment was obtained from the patient and the family.…”
Section: Methodsmentioning
confidence: 99%
“…Dystonic symptoms of adjacent or remote body parts were absent. Mean disease duration was 6.7 ± 6.6 years and the mean total writer's cramp rating scale (WCRS) (Wissel et al 1996) amounted to 9.7 ± 3.9. None of the participants had a history of other neurological or psychiatric disease, and neurological examination was normal except for focal hand dystonia in the patient group.…”
Section: Subjectsmentioning
confidence: 99%
“…Достаточно частое нежелательное явление -наличие слабости в руке после инъекции [18]. Комбинации мышц, рекомендуемые для инъекции, ва-рьируют в разных исследованиях, не определены опти-мальные дозы препарата БТА.…”
Section: Discussionunclassified